May 19 Quick Takes: Cowen closes $493M fund; plus Guangzhou BeBetter, Fountain Therapeutics, Amplyx, ChromaCode, Applied Molecular

Cowen raises $493M life sciences fund
Cowen Healthcare Investments closed its third life sciences fund at $493 million to invest in biopharma, diagnostics and digital health. LPs in Cowen Healthcare Investments III include institutional investors, family offices and high net worth individuals.

Lucky Source and Yuexiu back BeBetter’s series A
Guangzhou BeBetter Medicine Technology Co. Ltd. raised a “multi-hundred million” renminbi series A round led by Lucky Source Funds and Yuexiu Financial Holdings; Guangzhou Sanmei Investment also participated. BeBetter is developing therapeutics for cancer, non-alcoholic steatohepatitis (NASH), psoriasis and rheumatoid arthritis...